CFO transition
TransMedics Group, Inc. CFO transition: Fernando Araujo to succeed Gerardo Hernandez
TransMedics Group, Inc. reported in a Form 8-K filed September 10, 2026 that Fernando Araujo will succeed Gerardo Hernandez as Chief Financial Officer and Treasurer, effective September 21, 2026.
In the filing's words
On September 10, 2026, the Board of Directors (the “Board”) of TransMedics Group, Inc. (the “Company”) appointed Fernando Araujo as Chief Financial Officer and Treasurer, effective as of September 21, 2026. Mr. Araujo will succeed Gerardo Hernandez, who has served as the Company’s Chief Financial Officer since 2024.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | TransMedics Group, Inc. (TMDX) |
|---|---|
| Event | Transition |
| Incoming | Fernando Araujo |
| Outgoing | Gerardo Hernandez |
| Title in the filing | Chief Financial Officer and Treasurer |
| Effective | September 21, 2026 |
| 8-K filed | September 10, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Chief Financial Officer for GE Health Care's Advanced Imaging Solutions, GE Health Care |
| SEC CIK | 0001756262 |
TransMedics Group, Inc. reported this change in a Form 8-K, Item 5.02, filed September 10, 2026. The filing's own words are quoted above.
Other records naming Gerardo Hernandez
1The outgoing officer on this record, matched by name. Career line.
2026-02-24 · 10-K signature
Gerardo Hernandez signed TransMedics Group, Inc.'s annual report as Chief Financial Officer and Treasurer
Also filed in September 2026
Other CFO moves on the record that month. All moves.
6 weeks ago· 2026-09-30InterimACI
Albertsons Companies, Inc. names Cody Perdue interim CFO
6 weeks ago· 2026-09-30DepartureALDA
Atlantica Inc. discloses CFO departure: Shelley Goff
6 weeks ago· 2026-09-30TransitionCARL
Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein
6 weeks ago· 2026-09-30AppointmentLEVI
Levi Strauss & Co. appoints John Vandemore as CFO
6 weeks ago· 2026-09-30DeparturePTPI
Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein
6 weeks ago· 2026-09-30DepartureTCRX
TScan Therapeutics, Inc. discloses CFO departure: Jason A. Amello
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Fernando Araujo? Send a correction with the primary source.